Starton Therapeutics (Starton Therapeutics) Other Gross PPE : $1.73 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Other Gross PPE?

Starton Therapeutics's Other Gross PPE for the quarter that ended in Jun. 2023 was $1.73 Mil.

Starton Therapeutics's quarterly Other Gross PPE declined from Dec. 2022 ($1.79 Mil) to Mar. 2023 ($1.76 Mil) and declined from Mar. 2023 ($1.76 Mil) to Jun. 2023 ($1.73 Mil).

Starton Therapeutics's annual Other Gross PPE declined from Mar. 2021 ($1.89 Mil) to Mar. 2022 ($1.85 Mil) and declined from Mar. 2022 ($1.85 Mil) to Mar. 2023 ($1.76 Mil).

Starton Therapeutics Other Gross PPE Historical Data

The historical data trend for Starton Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Other Gross PPE Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Other Gross PPE

1.89

1.85

1.76

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Other Gross PPE	Get a 7-Day Free Trial			1.85	-	1.79	1.76	1.73

Starton Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines